Peter Powchik - Mar 31, 2022 Form 4 Insider Report for Vaxxinity, Inc. (VAXX)

Role
Director
Signature
/s/ Rene Paula Molina, attorney-in-fact for Peter Powchik
Stock symbol
VAXX
Transactions as of
Mar 31, 2022
Transactions value $
$0
Form type
4
Date filed
4/4/2022, 07:55 PM
Next filing
Jun 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VAXX Stock Option (right to buy) Award $0 +94.2K $0.00 94.2K Mar 31, 2022 Class A common stock 94.2K $4.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are subject to a three-year time-vesting schedule, with 31,395 shares vesting on the first and second anniversaries of the grant date and the remainder vesting on the third anniversary of the grant date.